Kunming Pharma Corp. announces several investment plans to boost its financial performance.

Kunming Pharma's subsidiary Gold-tide Bio-tech Co. intend to reinvest RMB 20million to renew its quality qualification to pass the new GMP certificate.

 Another wholly-owned sussidiary Xishuangbanna Pharma Co plans to spend RMB 6 million to renew its GMP certficate and RMB 19 million to found an reaseach centre. 

Those all investment plans have been considered as company's next 3-year development plan. And those plans have stimulate its stock market performance.